Century Therapeutics, Inc. (IPSC)
2.12
+0.05
(+2.42%)
USD |
NASDAQ |
Aug 24, 16:00
2.115
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Shareholders Equity (Quarterly) : 232.34M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 232.34M |
| March 31, 2026 | 264.74M |
| December 31, 2025 | 158.94M |
| September 30, 2025 | 176.35M |
| June 30, 2025 | 209.90M |
| March 31, 2025 | 240.44M |
| December 31, 2024 | 161.36M |
| September 30, 2024 | 195.69M |
| June 30, 2024 | 222.10M |
| March 31, 2024 | 177.88M |
| December 31, 2023 | 184.75M |
| September 30, 2023 | 219.23M |
| Date | Value |
|---|---|
| June 30, 2023 | 247.57M |
| March 31, 2023 | 277.18M |
| December 31, 2022 | 302.74M |
| September 30, 2022 | 330.20M |
| June 30, 2022 | 357.95M |
| March 31, 2022 | 386.66M |
| December 31, 2021 | 396.24M |
| September 30, 2021 | 422.99M |
| June 30, 2021 | 447.60M |
| March 31, 2021 | 247.83M |
| December 31, 2020 | 105.25M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 113.59M |
| Exicure, Inc. | 0.977M |
| Absci Corp. | 246.13M |
| Celularity, Inc. | -38.06M |
| Cardio Diagnostics Holdings, Inc. | 7.426M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.01M |
| Total Liabilities (Quarterly) | 54.66M |
| Debt to Equity Ratio | 0.1664 |
| Current Ratio | 8.280 |
| Net Debt Paydown Yield | 0.63% |